Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese

Journal of Endocrinological Investigation

Volumn 33, Issue 8, 2010, Pages 549-553

  Galli Tsinopoulou, A ^a   Grammatikopoulou, M G ^a   Stylianou, C ^a   Emmanouilidou, E ^a   Kokka, P ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Diabese; Dyslipidemia; Impaired glucose tolerance; Insulin resistance; Metabolic syndrome; Obese; Youth

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; URIC ACID; VON WILLEBRAND FACTOR;

ACANTHOSIS NIGRICANS; ADOLESCENT; ARTICLE; BODY FAT; BODY MASS; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRESCHOOL CHILD; PREVALENCE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; URIC ACID; VON WILLEBRAND FACTOR;

EID: 78049359017     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6868     Document Type: Article

References (30)

1. Kaufman FR. Diabesity. The obesity-diabetes epidemic that threatens America - and what we must do to stop it. New York: Bantam Books, 2006.
2. The "Diabesity" Epidemic: Let's Rehabilitate America. Available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1785206/. Accessed September 17, 2010.
3. Daly A. Diabesity: the deadly pentad disease. Diabetes Educ 1994, 20: 156-8.
4. Reaven GM. The metabolic syndrome requiescat in pace. Clin Chem 2005, 51: 931-8.
5. Bitsori M, Kafatos A. Dysmetabolic syndrome in childhood and adolescence. Acta Paediatr 2005, 94: 995-1005.
6. Chinali M, de Simone G, Roman MJ, et al. Cardiac markers of preclinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol 2008, 52: 932-8.
7. Das S, Zhang S, Mitchell D, Gidding SS. Metabolic syndrome with early aortic atherosclerosis in a child. J Cardiometab Syndr 2006, 1: 286-7.
8. rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998, 338: 1650-6.
9. Pacifico L, Cantisani V, Anania C, et al. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrin 2009, 160: 45-52.
10. Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2005, 31: 55-62.
11. Valle Jiménez M, Estepa RM, Camacho RM, Estrada RC, Luna FG, Guitarte FB. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 2007, 156: 497-502.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28: s37-42.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
14. Calcaterra V, Klersy C, Muratori T, et al. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 2008, 68: 868-72. (Pubitemid 351703935)
15. Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 2002, 26: 953-60.
16. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969, 44: 291-303.
17. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child 1970, 45: 13-23.
18. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004, 350: 2362-74.
19. Schulpis K, Karikas GA. Serum cholesterol and triglyceride distribution in 7767 school-aged Greek children. Pediatrics 1998, 101: 861-4. (Pubitemid 28204837)
20. López-Capapé M, Alonso M, Colino E, Mustieles C, Corbatón J, Barrio R. Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol 2006, 155: 313-9.
21. Galli-Tsinopoulou A, Grammatikopoulou MG, Stylianou C, Kokka P, Emmanouilidou E. A preliminary case-control study on nutritional status, body composition, and glycemic control of Greek children and adolescents with type 1 diabetes. J Diabetes 2009, 1: 36-42.
22. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006, 119 (Suppl 1): S10-6.
23. Boronat M, Saavedra P, Varillas VF, Novoa FJ. Use of confirmatory factor analysis for the identification of new components of the metabolic syndrome: The role of plasminogen activator inhibitor-1 and Haemoglobin A1c. Nutr Metab Cardiovasc Dis 2009, 19: 271-6.
24. Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond) 2006, 30: 1308-14.
25. Libby P. Inflammation in atherosclerosis. Nature 2002, 420: 868-74.
26. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997, 46: 860-7. (Pubitemid 27188265)
27. Greenfield JR, Campbell LV. Relationship between Inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2006, 2: 195-211.
28. Wojakowski W, Gminski J. Plasma levels of von willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease. Scand J Clin Lab Invest 2001, 61: 317-23.
29. d'Annunzio G, Vanelli M, Pistorio A, Minuto N, et al. Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biomed 2009, 80: 21-8.
30. Gallistl S, Sudi KM, Cvirn G, Muntean W, Borkenstein M. Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord 2001, 25: 529-32.